22-43881630-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138814.4(PNPLA5):āc.1127T>Cā(p.Met376Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,613,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00020 ( 0 hom., cov: 33)
Exomes š: 0.000018 ( 0 hom. )
Consequence
PNPLA5
NM_138814.4 missense
NM_138814.4 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 2.99
Genes affected
PNPLA5 (HGNC:24888): (patatin like phospholipase domain containing 5) This gene is a member of the patatin-like phospholipase family; its encoded protein has been shown to inhibit transacylation. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22891465).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPLA5 | NM_138814.4 | c.1127T>C | p.Met376Thr | missense_variant | 8/9 | ENST00000216177.9 | NP_620169.1 | |
PNPLA5 | NM_001177675.2 | c.785T>C | p.Met262Thr | missense_variant | 6/7 | NP_001171146.1 | ||
PNPLA5 | NM_001371410.1 | c.707T>C | p.Met236Thr | missense_variant | 8/9 | NP_001358339.1 | ||
PNPLA5 | XM_047441164.1 | c.707T>C | p.Met236Thr | missense_variant | 6/7 | XP_047297120.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPLA5 | ENST00000216177.9 | c.1127T>C | p.Met376Thr | missense_variant | 8/9 | 1 | NM_138814.4 | ENSP00000216177.3 | ||
PNPLA5 | ENST00000381198.7 | c.785T>C | p.Met262Thr | missense_variant | 6/7 | 2 | ENSP00000370595.2 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152158Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
30
AN:
152158
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000484 AC: 12AN: 247820Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134414
GnomAD3 exomes
AF:
AC:
12
AN:
247820
Hom.:
AF XY:
AC XY:
5
AN XY:
134414
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461380Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 726980
GnomAD4 exome
AF:
AC:
27
AN:
1461380
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
726980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 152158Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74318
GnomAD4 genome
AF:
AC:
30
AN:
152158
Hom.:
Cov.:
33
AF XY:
AC XY:
11
AN XY:
74318
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
8
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2023 | The c.1127T>C (p.M376T) alteration is located in exon 8 (coding exon 8) of the PNPLA5 gene. This alteration results from a T to C substitution at nucleotide position 1127, causing the methionine (M) at amino acid position 376 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;.;D
REVEL
Benign
Sift
Uncertain
.;D;.;D
Sift4G
Uncertain
D;D;D;D
Polyphen
P;P;D;D
Vest4
MVP
MPC
0.33
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at